Search

everythinglearnresearchcommunity

for

Search:↓

Calreticulin has roles in healing, immune response, and disease beyond its known functions in the endoplasmic reticulum.

Lichen Planus is a less common condition affecting skin and mucous membranes, with various types and associated risk factors, challenging to diagnose, significantly impacts life quality, and may have a risk of cancerous changes in oral lesions.

Chemotherapy can cause skin problems like hair loss, mouth sores, and skin darkening, and recognizing these can affect treatment decisions.

The conclusion is that accurate diagnosis of different types of hair loss requires good teamwork between skin doctors and lab experts.

The document concludes that recognizing and treating cutaneous lupus erythematosus early is crucial for managing the skin and potential systemic symptoms.

Lichen planus is a skin condition that can resolve on its own, is linked to hepatitis C, and increases the risk of skin cancer.

Taxane chemotherapy can cause skin, hair, and nail side effects, which are often under-reported and can affect patient quality of life.

Microneedles improve drug delivery in various body parts, are safe and painless, and show promise in cosmetology, vaccination, insulin delivery, and other medical applications.

Allergic reactions to blood thinners are rare but can be serious, requiring careful testing and alternative treatments.

Some drugs can cause skin, nail, and hair problems, which are important for healthcare professionals to recognize and report.

Postinflammatory hyperpigmentation causes dark skin patches and needs personalized treatment.

Correct skin biopsy techniques are crucial to avoid misdiagnosis of skin diseases.

Treatments for permanent hair loss from scarring aim to stop further loss, not regrow hair, and vary by condition, with partial success common.

Lichen planus pigmentosus causes dark skin patches and is treated by avoiding triggers and using anti-inflammatory medications.

Lichen planopilaris is a chronic, scarring hair loss condition with no definitive cure, requiring accurate diagnosis and treatment to manage symptoms.

The document concludes that accurate diagnosis of different types of hair loss requires careful examination of hair and scalp tissue, considering both clinical and microscopic features.

Toxic epidermal necrolysis is a severe skin condition often caused by drugs, with complex treatment and a high risk of death, but survivors usually heal without scars.

Skin problems are very common in people with end-stage kidney disease.

A deficiency in the TTC7A gene causes immune problems, gut issues, and hair loss.

There are still challenges in diagnosing and treating chronic skin diseases, but there is hope for future improvements.

Finasteride increases hair density in female androgenetic alopecia, but individual results may vary.

Understanding the genetics of rare inherited ichthyosis syndromes is key for better treatments and genetic counseling.

Hair loss is common in lupus patients and can be permanent or reversible, depending on the type, with various treatments available.

Botulinum toxin has potential for treating various skin conditions and improving wound healing.

Lupus can affect the scalp and nails, often causing hair loss and nail damage, and needs early aggressive treatment to prevent permanent damage.

Accurate diagnosis is key for treating different kinds of hair loss, and immune response variations may affect the condition and treatment results.

A woman with subacute cutaneous lupus erythematosus had widespread skin symptoms triggered by medication and sunlight, which improved with specific treatments.

Special immune cells called Tregs can help prevent lung scarring by blocking a specific growth factor.

The document concludes that inherited epidermolysis bullosa is a challenging genetic condition requiring multidisciplinary care and new treatments.

Skin problems are common in lupus, important for diagnosis, and can be triggered by sunlight.